europeptides in the human intra - and extracerebral circulation - before and after affecting the trigeminovascular system with sumatriptan in healthy volunteers. - Neuropeptidstudy
Phase 1
- Conditions
- healthy volunteers
- Registration Number
- EUCTR2006-002677-41-DK
- Lead Sponsor
- Danishy Headache Center, KAS Glostrup, Dep. N01
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
healthy non-pregnant volunteers without any serious medical conditions.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
pregnancy.
Serious medical conditions.
Allergy to sumatriptan.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method